Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Suee Lee, Dae Ho Lee, Jong Ho Won, In Gyu Hwang, Min Kyoung Kim, Soon Il Lee, Yee Soo Chae, Deok Hwan Yang, Hye Jin Kang, Chul Won Choi, Jinny Park, Hyo Jung Kim, Jung Hye Kwon, Ho Sup Lee, Gyeong Won Lee, Hyeon Seok EomJae Yong Kwak, Cheolwon Suh, Hyo Jin Kim

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study'. Together they form a unique fingerprint.

Medicine & Life Sciences